| Characteristics | All |
| Number | 246 |
| Mean Age, years (SD) | 34.8 (10.8) |
| Female Sex | 222 (90%) |
| Race/Ethnicity | All |
| White | 190 (77%) |
| Latinx | 34 (15%) |
| Black-African American | 15 (6%) |
| Black-African | 8 (3%) |
| Asian |
6 (2%) |
| Other | 10 (4%) |
| Comorbidities | All |
| Obesity | 157 (64%) |
| Pulmonary disease | 64 (28%) |
| Tobacco smoking | 43 (17%) |
| Diabetes | 16 (6%) |
| CV disease | 6 (2%) |
| COVID-19 Medications | All |
| No treatment | 161 (65%) |
| Azithromycin | 36 (15%) |
| Corticosteroids | 32 (13%) |
| Oxygen supplementation | 20 (8%) |
| Anti-viral | 8 (3%) |
| Anti-malarial | 5 (2%) |
| IL-6 inhibitor | 1 (1%) |
| COVID-19 Complications | All |
| No serious events | 131 (53%) |
| HS flare | 70 (31%) |
| Shortness of breath | 38 (17%) |
| Sepsis | 2 (1%) |
| Death | 0 (0%) |
| COVID-19 Treatment Location | All |
| In hospital treatment | 19 (8%) |
| ED treatment | 36 (15%) |
| Home | 200 (81%) |